chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient did not experience any side effects; A patient was administered MMR II that expired on 11MAY2022; This spontaneous report was received from an office manager, concerning a 1-year-old male patient.without pre-existing medical conditions, allergies, birth defects or illness at the time of vaccination. He had none adverse event following prior vaccinations. The patient did not received any other vaccine 4 weeks prior to receive Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II). He was not taking any concomitant medications.  On 25-JUL-2022, the patient was vaccinated with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (rHA) subcutaneous injection, administered as prophylaxis in the left arm, lot number T016197 with expiration date 11-MAY-2022 (dosage regimen was not provided). After the administration, it was noted that the vaccine was expired (Expired product administered).  The reporter stated that the vaccine should had been removed from the vaccine refrigerator, so no one could grab it to the patient. Additionally, the reporter stated that the expiration date should had been verified prior to the administration. The vaccine did not have any temperatures excursion (TEs). The patient did not experience any side effects. There was not prescription drug treatment required (No adverse event).  The reporter stated that on te same day, the patient recovered from the expired product administered and considered that it was related to Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II).
Patient reported having covid-related dizziness/lightheadedness/ sweating after more than 30 minutes after administration of the Moderna covid vaccination. This was the patient's 2nd dose as with the 1st dose the patient only reported arm soreness. At the scene, 4 EMT persons came to check the patient's blood pressure (160/90 mmHg), after the patient sat down, the patient was reported to be doing fine. After EMT consultation and observation, the patient was allowed to go home with his family.
This case was reported by a pharmacist  and described the occurrence of injection site soreness in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine for prophylaxis. On an unspecified date on or after 10/18/05 and on or before 10/28/05 the subject received a dose of Fluarix. The site of injection of the Fluarix was not provided. On an unspecified date in 10/05, less than one month after vaccination with Fluarix, the subject experienced injection site soreness. The subject "sought medical attention." The injection site soreness resolved on an unspecified date on or before 11/28/05.
Swelling of the tongue, Tingling sensation in roof of mouth, Unusual metallic taste in mouth
Shortness of breath; Stomach ache; Fever; Chills; Nausea; Tiredness; Headache; Vomiting; A spontaneous report was received from a consumer who was a 46 year female patient, who received Moderna's COVID-19 Vaccine and experienced fever, chills, nausea, tiredness, headache, vomiting, stomachache and shortness of breath.  The patient's medical history was not reported. Concomitant medication included Ropinirole.  On an unreported date, the patient received the first of two planned doses of mRNA-1273 (batch number: 039J20A) intramuscularly in her left deltoid for prophylaxis of COVID-19 infection.  On 07 JAN 2021, the patient experienced fever, chills, nausea, tiredness, headache, vomiting, stomachache and shortness of breath.  Treatment for the events was not reported.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events fever, chills, nausea, tiredness, headache, vomiting, stomachache and shortness of breath were not reported.; Reporter's Comments: This case concerns a 46 year old female who experienced nonserious unexpected events of stomachache and shortness of breath and nonserious expected events of fever, chills, nausea, tiredness, headache, and vomiting. The events occurred an unknown time after first dose of mRNA-1273 administration.  Treatment for the events was not reported.  Based on the current available information and temporal association between the use of mRNA-1273 and the start date of the events, a causal relationship cannot be excluded.
Follow up: Patient received casirivimab instead of intended COVID vaccine.  48-hr follow up didn't identify AEs. Patient received COVID vaccine on December 31
On going head aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (On going head aches) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not known.) for COVID-19 vaccination.     Skin cancer.  The patient's past medical history included Skin cancer.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (On going head aches). At the time of the report, HEADACHE (On going head aches) had not resolved.            No Concomitant medications were reported. No Treatment information was reported.
Mom states that babys is not sleeping a lot of congestion , coughing , Body pain mom states that she use to be very active and since they put the last vaccine she changes .  Gi symptoms, diarrhea and vomiting x 1 day, continues with soft stools x 4 times a day (watery)- mom attributes to vaccine received
Narrative:  Per Allergy/Immunology note 4/16: "received pfizer covid vaccine 3/22/21. Presented 4/12 for 2nd injection and reported to vaccinator that she had a  scratchy throat, swollen tongue and tonsils starting a couple minutes after and for 1 hour after 1st covid injection (after leaving vaccination area). Stated tongue felt heavy, numb, swollen, red swollen tonsils. Took loratadine when she got home and  back to normal one hour later. She had muscle aches and felt flu symptoms, fever 100.2 4 days later.
The pt experienced a swollen left leg, erythema and was advised to take Benadryl and Ibuprofen. Treate with cool compresses.
Injection site became red, swollen, itchy and tender at day 7/8.  Injection site after 24 hours of injection was sore but pain went away.  Issues started at day 7/8.  Called PCP and was instructed to take Ibuprofen, Claritin and put cold compress on site.  Followed up with PCP next day to give update.
soreness in the injection site; This case was reported by a consumer and described the occurrence of injection site pain in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In December 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were reported as follows: The age at the vaccination was not reported. The patient received Shingrix and experienced only soreness in the injection site. This case has been linked with case US2020AMR108489, reported by same reporter for the 2nd dose.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR108489:
Diagnosed with cellulitis on 10/13 (4 days post vaccination) at site of injection at Emergency Room in hospital-given cephalexin and famotidine and discharged.
Malaise, body aches, fatigue, headache, nausea, loss of appetite, severe pain and swelling in arm within hours. Within two days developed bright red rash over right upper arm on top of the severe swelling. Seen on day 5 with 101 fever still No treatments had been tried. Started on 1000mg acetaminophen and 10mg cetirizine BID for duration of reaction. Improved on day two but arm rash got bigger. Overall patient feeling improved today  while taking medications (2/1/2022). Has additional follow-up tomorrow.
Within two or three minutes after receiving vaccine, individual began to complain of feeling light headed and vertigo.  Blood pressure was normal before vaccine and elevated during time of complaint.  Reaction lasted about 30 minutes.
This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm and frozen shoulder. On an unknown date, the outcome of the pain in arm and frozen shoulder were unknown. It was unknown if the reporter considered the pain in arm and frozen shoulder to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine formulation. The reporter did not have additional details on the incidents. She needed to check records for details but agreed to provide more information on follow up. No other information was received.
I felt a slight fever and chills last night, nausea and passed out this morning (5am). Headache, nauseous and still warm now (9:58 am). Very achy.
Last week she was having problems in her left arm; Having problems in back of neck, pain goes from one side of the neck to the other; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Last week she was having problems in her left arm) and NECK PAIN (Having problems in back of neck, pain goes from one side of the neck to the other) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 2VONS2115) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Last week she was having problems in her left arm) and NECK PAIN (Having problems in back of neck, pain goes from one side of the neck to the other). At the time of the report, PAIN IN EXTREMITY (Last week she was having problems in her left arm) and NECK PAIN (Having problems in back of neck, pain goes from one side of the neck to the other) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I developed Chronic Hives on 11/21/20221 after receiving the Covid-19 booster on 11/09/2021. The chronic hives still persist to this day. The hives are severe and required an urgent care and ER visit. Without multiple types of allergy medication, the chronic hives are severe and debilitating, developing all over the body from feet to head causing pain and severe itching . I am now receiving monthly allergy shots. I reported the hives to the Pharmacy and the pharmacist communicated that he had received multiple reports of customers developing Chronic hives after receiving the covid vaccine. Many sick days were taken because of the Chronic Hives and may affect my ability to do my job long-term if I?m unable to continue to manage my symptoms. The hives have become progressively worse over time and require more medication & sooner allergy shots as time goes on.
immed soft tissue swelling, erythema, induration 3cm about inj site;no resp systemic rxn;
Patient was given vaccine in our administration area and asked to remain sitting in the chair until she felt ready to stand up. When she felt ready, she stood up and her male partner sat down to receive his vaccine. His vaccine was administered and both patients were alert and talking to one another. As I turned my back to return to the pharmacy, I heard a loud thud and realized the female patient had fainted and hit her head on either the pharmacy counter or the floor. Staff was called and an incident report filed. EMS was called and checked her on the scene but further care from them was refused by the patient. Patient was advised to report to an ER but decided to get checked out at a nearby Urgent Care.
Bell's Palsy; body aches; Pain in the head; Neck pain; Jaw pain; A spontaneous reportwas received from a 56-years-old, female patient who experienced jaw pain, neck pain, pain in the head, body aches and bells palsy.    The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included levothyroxine sodium, fluticasone propionate, loratadine, vitamin E, vitamin B, vitamin C, ibuprofen and tizanidine.   On 26 Jan 2021, approximately fifteen days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 [Lot number 2039K20A] intramuscularly for prophylaxis of COVID-19 infection.   On 10 Feb 2021, the patient experienced jaw pain, neck pain, head pain and body aches.   On 14 Feb 2021, she was diagnosed with Bells palsy after going to urgent care . Treatment for the event included valaciclovir hydrochloride, salve for eye, steroid ear drop.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events jaw pain, neck pain, pain in the head, body aches and bell's palsy were unknown.; Reporter's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
Initial unsolicited report received from a physician via other company (Pfizer) (Manufacturer Report Number: 2017076814) on 07-Mar-2017. This case involves a female patient (onset age not reported) who was vaccinated with a dose of TETANUS VACCINE AND TOXOID (batch number, expiration date, dose, dose in series, route and site of administration were not reported) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date following vaccination (Latency unknown), the patient experienced allergy to tetanus vaccines and toxoid. Laboratory investigations and corrective treatment were not reported. The outcome of the event was not reported. List of documents held by sender: none.
Throat felt like it was closing and had difficulty swallowing (that subsided quickly) 45 minutes after the shot, the right side of my face felt numb and tingly (Felt like when novocaine is wearing off.) Continued for 48 hours and worsened with slight drooping when smiling. Clearing my throat a lot and my right eye keeps tearing up. The doctor confirmed it was "Bell's Palsy" this morning and I have been put on Prednisone.
severe muscle spasm in Left thigh, nerve pain in center of palms numbness and tingling bilateral fingers 20 minutes after dose, Followed   by feeling sick for two weeks (missed work) subsequent muscle spasms bilateral legs, joint pain in bilateral shoulders, hips, knees and ankles, nerve pain in both hands and both feet, burning sensations, eye pain and substantial muscle weakness impacting ability to lift and carry.
I am having some reaction to the booster shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I am having some reaction to the booster shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I am having some reaction to the booster shot). At the time of the report, VACCINATION COMPLICATION (I am having some reaction to the booster shot) outcome was unknown.            The patient stated that they were having some reaction to the booster shot.   No Concomitant product use was reported. No treatment information was provided.
I?ve had soreness for the last two day in my upper left arm at the injection site. Pain feels like someone punched me and left a bruise. No visible bruise.  Dull headache as well. I?ve been taking over the counter medication for the headache.
This spontaneous report was received from an unspecified reporter and refers to a patient of unknown age. On 23-JUN-2016, the patient was vaccinated with improperly stored dose of VARIVAX (dose, frequency, route of administration and indication were not reported lot# L041206 with expiration date 20-OCT-2017). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, SARS-CoV-2 antibody test: positive (Positive) SARS-CoV-2 antibody test positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use information was not provided by reporter  Treatment medication use information was not provided by reporter   Most recent FOLLOW-UP information incorporated above includes: On 27-Jun-2021: TCR received on 27/Jun/2021 contains No New Information. Patient completely asymptomatic.
Slight fever; Body aches; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (Slight fever) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Slight fever) and MYALGIA (Body aches). At the time of the report, PYREXIA (Slight fever) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
hallucinations; very sick; unable to move/unable to get out of bed; pain throughout my entire body; Vomiting; swelling; lost of appetite for 2 days; This is a spontaneous report from a non-contactable consumer (patient). A 36-year-old male patient received the second dose of BNT162B2 (PFIZER COVID-19 VACCINE, lot number: EW0182), at the age of 36 years old, in left arm on 20May2021 10:15 at single dose for covid-19 immunisation. The patient medical history was none. The patient had no known allergies. The patient was not diagnosed with covid-19 prior to vaccination. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162B2 (lot number: EW0170), at the age of 36 years old, in left arm on 29Apr2021 10:15 at single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to vaccination. The patient became very sick, unable to move, unable to get out of bed, incredible pain throughout his entire body, vomiting, swelling, hallucinations and lost of appetite for 2 days on 20May2021 23:00. The patient had not been tested for covid-19 since the vaccination. The treatment for events was unknown. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Client vaccinated with Pfizer vaccines x 2 in November 2021.  Symptoms started on 12/20 - fever 101.9 F., with headache, myalgia.
Day after immunizations began having neck pain with radiation down back; right arm discomfort and then later in week right knee lateral discomfort and right lateral small toe discomfort, Symptoms not worsening, but not resolved 8 day later.  Also 8 days later had slightly reduced subjective sensation left arm and left leg, not worsening.  Patient given Ibuprofen for inflammation and Flexeril for muscle spasm.  Exam revealed no neurologic deficit or swelling or erythema.  Mild muscle spasm, neck and mild tenderness neck, right arm, right lateral knee and right lateral 5th toe.
After vaccine was administered patient received heart racing and fluttering. Patient was seen by doctor and instructed to wear a heart monitor. Doctor then had patient report to the emergency department after reviewing heart monitor data. Patient was admitted to the hospital and started on a beta blocker.
About 1 hours, post vax, face got red and puffy; no SOB. Was instructed to take Benadryl and it resolved.
I noticed that the ROTATEQ was leaking out of the neck of the tube instead of coming out of the top of the tube; I noticed that the ROTATEQ was leaking out of the neck of the tube instead of coming out of the top of the tube; I noticed that the ROTATEQ was leaking out of the neck of the tube instead of coming out of the top of the tube; I noticed that the ROTATEQ was leaking out of the neck of the tube instead of coming out of the top of the tube; This spontaneous report was received from a nurse and physician via company representative referring to a patient of unknown age and gender. Information about patient's concurrent condition, concomitant medication, medical history and drug allergy/reaction was not reported.  On 16-APR-2020, the nurse was administrating rotavirus vaccine, live, oral, pentavalent(ROTATEQ) to a patient and noticed that rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (lot # 1660947, expiry date: 16-FEB-2021) was leaking out of the neck of the tube instead of coming out of the top of the tube (product quality issue, product leakage, accidental exposure to product and circumstance or information capable of leading to medication error), immediately stopped and administered a new rotavirus vaccine, live, oral, pentavalent(ROTATEQ) without difficulty on same visit for prophylaxis (strength, dose, dose number, route, lot/batch #, expiry date was not reported). It was also reported that the nurse had difficulty breaking the seal of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) every time while administering from past a year and half, so used the needle to break the seal.
Nausea, aches, fatigue,  swelling/soreness/itchiness  at injection site
sore arm (inject site; slight fever (1.5 F); moderate headache; very tired > all lasted12+ hr (ok next morning
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 68 years, in left arm for Covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history included: "Known allergies: multiple" (unspecified if ongoing), notes: Known allergies: multiple. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 04Jun2022, outcome "unknown" and all described as "Pfizer / BioNTech Dose Number: 4/ Treatment of COVID-19 04Jun2022". Therapeutic measures were taken as a result of drug ineffective, suspected Covid-19. Patient received treatment with Paxlovid for COVID-19. Treatment start date=04Jun2022,Treatment stop date=04Jun2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
On 10/21 the plain Pfizer Vaccine was administered to this patient. She was supposed to receive the PFIZER-BIVALENT DOSE (NOT the orig.vacc)!!!
Edema erythema and tenderness entire lateral arm extending almost to elbow, extensor surface.